190 related articles for article (PubMed ID: 19052086)
1. The C proteins of human parainfluenza virus type 1 (HPIV1) control the transcription of a broad array of cellular genes that would otherwise respond to HPIV1 infection.
Boonyaratanakornkit JB; Bartlett EJ; Amaro-Carambot E; Collins PL; Murphy BR; Schmidt AC
J Virol; 2009 Feb; 83(4):1892-910. PubMed ID: 19052086
[TBL] [Abstract][Full Text] [Related]
2. The C proteins of human parainfluenza virus type 1 limit double-stranded RNA accumulation that would otherwise trigger activation of MDA5 and protein kinase R.
Boonyaratanakornkit J; Bartlett E; Schomacker H; Surman S; Akira S; Bae YS; Collins P; Murphy B; Schmidt A
J Virol; 2011 Feb; 85(4):1495-506. PubMed ID: 21123378
[TBL] [Abstract][Full Text] [Related]
3. Human parainfluenza virus type 1 C proteins are nonessential proteins that inhibit the host interferon and apoptotic responses and are required for efficient replication in nonhuman primates.
Bartlett EJ; Cruz AM; Esker J; Castaño A; Schomacker H; Surman SR; Hennessey M; Boonyaratanakornkit J; Pickles RJ; Collins PL; Murphy BR; Schmidt AC
J Virol; 2008 Sep; 82(18):8965-77. PubMed ID: 18614629
[TBL] [Abstract][Full Text] [Related]
4. Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1.
Van Cleve W; Amaro-Carambot E; Surman SR; Bekisz J; Collins PL; Zoon KC; Murphy BR; Skiadopoulos MH; Bartlett EJ
Virology; 2006 Aug; 352(1):61-73. PubMed ID: 16750233
[TBL] [Abstract][Full Text] [Related]
5. A novel human parainfluenza virus type 1 (HPIV1) with separated P and C genes is useful for generating C gene mutants for evaluation as live-attenuated virus vaccine candidates.
Bartlett EJ; Cruz AM; Boonyaratanakornkit J; Esker J; Castaño A; Skiadopoulos MH; Collins PL; Murphy BR; Schmidt AC
Vaccine; 2010 Jan; 28(3):767-79. PubMed ID: 19857454
[TBL] [Abstract][Full Text] [Related]
6. The C proteins of human parainfluenza virus type 1 block IFN signaling by binding and retaining Stat1 in perinuclear aggregates at the late endosome.
Schomacker H; Hebner RM; Boonyaratanakornkit J; Surman S; Amaro-Carambot E; Collins PL; Schmidt AC
PLoS One; 2012; 7(2):e28382. PubMed ID: 22355301
[TBL] [Abstract][Full Text] [Related]
7. Attenuation and efficacy of human parainfluenza virus type 1 (HPIV1) vaccine candidates containing stabilized mutations in the P/C and L genes.
Bartlett EJ; Castaño A; Surman SR; Collins PL; Skiadopoulos MH; Murphy BR
Virol J; 2007 Jul; 4():67. PubMed ID: 17605811
[TBL] [Abstract][Full Text] [Related]
8. Role of interferon in the replication of human parainfluenza virus type 1 wild type and mutant viruses in human ciliated airway epithelium.
Bartlett EJ; Hennessey M; Skiadopoulos MH; Schmidt AC; Collins PL; Murphy BR; Pickles RJ
J Virol; 2008 Aug; 82(16):8059-70. PubMed ID: 18524813
[TBL] [Abstract][Full Text] [Related]
9. Human parainfluenza virus type 1 but not Sendai virus replicates in human respiratory cells despite IFN treatment.
Bousse T; Chambers RL; Scroggs RA; Portner A; Takimoto T
Virus Res; 2006 Oct; 121(1):23-32. PubMed ID: 16677733
[TBL] [Abstract][Full Text] [Related]
10. Introducing point and deletion mutations into the P/C gene of human parainfluenza virus type 1 (HPIV1) by reverse genetics generates attenuated and efficacious vaccine candidates.
Bartlett EJ; Amaro-Carambot E; Surman SR; Collins PL; Murphy BR; Skiadopoulos MH
Vaccine; 2006 Mar; 24(14):2674-84. PubMed ID: 16364511
[TBL] [Abstract][Full Text] [Related]
11. Alix serves as an adaptor that allows human parainfluenza virus type 1 to interact with the host cell ESCRT system.
Boonyaratanakornkit J; Schomacker H; Collins P; Schmidt A
PLoS One; 2013; 8(3):e59462. PubMed ID: 23527201
[TBL] [Abstract][Full Text] [Related]
12. Host range restriction of parainfluenza virus growth occurs at the level of virus genome replication.
Tao T; Ryan KW
Virology; 1996 Jun; 220(1):69-77. PubMed ID: 8659130
[TBL] [Abstract][Full Text] [Related]
13. Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine.
Mackow N; Amaro-Carambot E; Liang B; Surman S; Lingemann M; Yang L; Collins PL; Munir S
J Virol; 2015 Oct; 89(20):10319-32. PubMed ID: 26223633
[TBL] [Abstract][Full Text] [Related]
14. Generation of recombinant human parainfluenza virus type 1 vaccine candidates by importation of temperature-sensitive and attenuating mutations from heterologous paramyxoviruses.
Newman JT; Riggs JM; Surman SR; McAuliffe JM; Mulaikal TA; Collins PL; Murphy BR; Skiadopoulos MH
J Virol; 2004 Feb; 78(4):2017-28. PubMed ID: 14747566
[TBL] [Abstract][Full Text] [Related]
15. Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F.
Liu X; Liang B; Ngwuta J; Liu X; Surman S; Lingemann M; Kwong PD; Graham BS; Collins PL; Munir S
J Virol; 2017 Nov; 91(22):. PubMed ID: 28835504
[TBL] [Abstract][Full Text] [Related]
16. The long noncoding region of the human parainfluenza virus type 1 f gene contributes to the read-through transcription at the m-f gene junction.
Bousse T; Matrosovich T; Portner A; Kato A; Nagai Y; Takimoto T
J Virol; 2002 Aug; 76(16):8244-51. PubMed ID: 12134030
[TBL] [Abstract][Full Text] [Related]
17. Sendai virus, a murine parainfluenza virus type 1, replicates to a level similar to human PIV1 in the upper and lower respiratory tract of African green monkeys and chimpanzees.
Skiadopoulos MH; Surman SR; Riggs JM; Elkins WR; St Claire M; Nishio M; Garcin D; Kolakofsky D; Collins PL; Murphy BR
Virology; 2002 May; 297(1):153-60. PubMed ID: 12083845
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of the human parainfluenza virus type 1 F gene downregulates HN expression.
Bousse T; Takimoto T; Murti KG; Portner A
Virology; 1997 May; 232(1):44-52. PubMed ID: 9185587
[TBL] [Abstract][Full Text] [Related]
19. Two regions of the P protein are required to be active with the L protein for human parainfluenza virus type 1 RNA polymerase activity.
Bousse T; Takimoto T; Matrosovich T; Portner A
Virology; 2001 May; 283(2):306-14. PubMed ID: 11336555
[TBL] [Abstract][Full Text] [Related]
20. The P genes of human parainfluenza virus type 1 clinical isolates are polycistronic and microheterogeneous.
Power UF; Ryan KW; Portner A
Virology; 1992 Jul; 189(1):340-3. PubMed ID: 1318610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
